Published in J Hypertens on May 01, 2010
Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects. Circulation (2015) 1.67
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension (2012) 1.30
Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension. Circulation (2016) 1.19
The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol (Oxf) (2011) 1.03
Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension. J Hum Hypertens (2010) 1.00
Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab (2012) 0.97
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. J Renin Angiotensin Aldosterone Syst (2011) 0.92
Characteristics of sodium sensitivity in Korean populations. J Korean Med Sci (2011) 0.87
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens (2012) 0.87
Polymorphisms in the serum- and glucocorticoid-inducible kinase 1 gene are associated with blood pressure and renin response to dietary salt intake. J Hum Hypertens (2012) 0.85
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 0.84
Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance. Metabolism (2011) 0.82
Influence of Salt Intake on Association of Blood Uric Acid with Hypertension and Related Cardiovascular Risk. PLoS One (2016) 0.81
Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism. J Clin Endocrinol Metab (2015) 0.81
Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake. Hypertension (2015) 0.77
A randomised controlled trial evaluating the effect of potassium supplementation on vascular function and the renin-angiotensin-aldosterone system. J Hum Hypertens (2013) 0.77
The Effects of High-Sodium Intake on Systemic Blood Pressure and Vascular Responses in Spontaneously Diabetic WBN/Kob-Lepr(fa/fa) Rats. Clin Exp Pharmacol Physiol (2016) 0.75
Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intake. Age (Dordr) (2012) 0.75
Low Response of Renin-Angiotensin System to Sodium Intake Intervention in Chinese Hypertensive Patients. Medicine (Baltimore) (2016) 0.75
Hydrogen Sulfide Inhibits High-Salt Diet-Induced Myocardial Oxidative Stress and Myocardial Hypertrophy in Dahl Rats. Front Pharmacol (2017) 0.75
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension (1994) 1.80
Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension (1999) 1.64
Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest (1974) 1.59
Renal function and blood pressure response to dietary salt restriction in normotensive men. Hypertension (1996) 1.56
The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol (1999) 1.38
Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension (1991) 1.23
The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Nephrol (2008) 1.15
Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol (1986) 1.09
Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int (2003) 1.06
Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension (2002) 1.03
Altered renal handling of sodium in human hypertension: short review of the evidence. Hypertension (2003) 1.02
Central role of the kidney and abnormal fluid volume control in hypertension. J Hum Hypertens (1996) 0.93
Parallel adrenal and renal abnormalities in young patients with essential hypertension. Am J Med (1982) 0.93
Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus. Kidney Int (2001) 0.90
Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. J Clin Invest (1979) 0.90
Sodium-sensitive essential hypertension: emerging insights into an old entity. J Am Coll Nutr (1989) 0.89
Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man. J Clin Endocrinol Metab (1983) 0.88
Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension. Clin Sci (Lond) (1984) 0.80
Salt sensitivity in hypertension: implications for the kidney. J Am Soc Nephrol (1991) 0.80
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation (2003) 3.49
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Uric acid and the development of hypertension: the normative aging study. Hypertension (2006) 2.45
Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44
Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function. Endocrinology (2014) 2.17
Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension (2007) 1.98
Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension (2011) 1.85
A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol (2008) 1.85
Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab (2007) 1.78
Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation (2008) 1.73
Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans. Am J Hypertens (2011) 1.72
Beta-2 adrenergic receptor diplotype defines a subset of salt-sensitive hypertension. Hypertension (2006) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
50th anniversary of aldosterone. J Clin Endocrinol Metab (2003) 1.70
Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension (2010) 1.69
Effect of acute aldosterone administration on gene expression profile in the heart. Endocrinology (2006) 1.58
A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens (2011) 1.57
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol (2006) 1.56
Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension (2013) 1.55
Aldosterone--villain or bystander? N Engl J Med (2004) 1.49
Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women. Menopause (2008) 1.49
Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology (2006) 1.34
Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens (2003) 1.34
Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int (2004) 1.24
Genetics of human hypertension. Trends Endocrinol Metab (2005) 1.23
Aldosterone production and insulin resistance in healthy adults. J Clin Endocrinol Metab (2010) 1.23
Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry (2006) 1.20
The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism (2011) 1.15
Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after prolonged bed rest. J Appl Physiol (1985) (2003) 1.14
25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst (2011) 1.13
Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care (2003) 1.11
Effect of dietary sodium on vasoconstriction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol (2008) 1.11
Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension (2002) 1.10
Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab (2004) 1.09
Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects. J Am Soc Nephrol (2007) 1.07
Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome. Hypertension (2010) 1.06
Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int (2003) 1.06
Low-salt diet increases insulin resistance in healthy subjects. Metabolism (2010) 1.06
Genetic determinants of nonmodulating hypertension. Hypertension (2003) 1.06
Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol (2010) 1.05
The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol (Oxf) (2011) 1.03
Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt. Hypertension (2002) 1.03
Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II. Endocrinology (2010) 1.03
The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) (2011) 0.99
Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension. J Clin Endocrinol Metab (2011) 0.98
Plasma aldosterone concentration in the patient with diabetes mellitus. Kidney Int (2004) 0.98
Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension. J Clin Endocrinol Metab (2007) 0.98
Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway. Cancer (2014) 0.98
Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study. J Clin Endocrinol Metab (2012) 0.97
The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol (2011) 0.97
Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes. J Hypertens (2010) 0.97
C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis (2007) 0.96
Relationship between aldosterone and progesterone in the human menstrual cycle. J Clin Endocrinol Metab (2006) 0.96
Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice. J Pharmacol Exp Ther (2013) 0.95
Abnormal aldosterone physiology and cardiometabolic risk factors. Hypertension (2013) 0.95
Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension. Am J Physiol Heart Circ Physiol (2011) 0.94
Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension. Circulation (2002) 0.93
Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension (2002) 0.93
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. J Renin Angiotensin Aldosterone Syst (2011) 0.92
Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder. Psychoneuroendocrinology (2004) 0.90
Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern. Am J Clin Nutr (2010) 0.88
Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk. Hypertension (2014) 0.88
Activation of the mineralocorticoid receptor increases striatin levels. Am J Hypertens (2011) 0.87
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens (2012) 0.87
The association of plasma resistin with dietary sodium manipulation, the renin-angiotensin-aldosterone system, and 25-hydroxyvitamin D3 in human hypertension. Clin Endocrinol (Oxf) (2011) 0.87
Cell membrane-associated mineralocorticoid receptors? New evidence. Hypertension (2011) 0.86
Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women. Clin Endocrinol (Oxf) (2004) 0.86
Simulated microgravity induces microvolt T wave alternans. Ann Noninvasive Electrocardiol (2005) 0.86
The relationship between peroxisome proliferator-activated receptor-gamma and renin: a human genetics study. J Clin Endocrinol Metab (2010) 0.86
Why is orthostatic tolerance lower in women than in men? Renal and cardiovascular responses to simulated microgravity and the role of midodrine. J Investig Med (2006) 0.86
Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity. J Am Soc Nephrol (2002) 0.86
No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels. Diabetes (2012) 0.86
Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats. J Endocrinol (2008) 0.85
Rationale for the use of aldosterone antagonists in congestive heart failure. Drugs (2002) 0.85
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 0.84
Dietary sodium intake regulates angiotensin II type 1, mineralocorticoid receptor, and associated signaling proteins in heart. J Endocrinol (2011) 0.84
Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives. Free Radic Biol Med (2003) 0.84
The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology (2012) 0.84
Familial aggregation of insulin resistance and cardiovascular risk factors in hypertension. J Clin Hypertens (Greenwich) (2006) 0.84
Aggregation of high-normal thyroid-stimulating hormone in hypertensive families. J Clin Endocrinol Metab (2005) 0.84
Sex differences in the genetic basis of morning serum cortisol levels: genome-wide screen identifies two novel loci specific to women. J Clin Endocrinol Metab (2005) 0.83
Direct renin inhibition modulates insulin resistance in caveolin-1-deficient mice. Metabolism (2012) 0.83
Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization. Am J Physiol Heart Circ Physiol (2011) 0.83
The association of the angiotensinogen gene with insulin sensitivity in humans: a tagging single nucleotide polymorphism and haplotype approach. Metabolism (2011) 0.83